VICTOZA LIRAGLUTIDE Injection
₹4,259.00 Including TAX
Save 20%
For adults with type 2 diabetes with known heart disease, Victoza® reduces the risk of major cardiovascular events such as heart attack, stroke, or death. Victoza® is not for use in people with type 1 diabetes. It should not be used with other medicines that contain liraglutide. It is not known if Victoza® is safe and effective to lower blood sugar in children under 10 years of age.
Victoza® is a once-daily noninsulin medicine that lowers blood sugar and A1C.
For adults with type 2 diabetes with known heart disease, Victoza® reduces the risk of major cardiovascular events such as heart attack, stroke, or death. Victoza® is not for use in people with type 1 diabetes. It should not be used with other medicines that contain liraglutide. It is not known if Victoza® is safe and effective to lower blood sugar in children under 10 years of age.
MANUFACTURER/ MARKETER – Novo Nordisk India Pvt Ltd
SALT COMPOSITION – Liraglutide (6mg/ml)
Store in a refrigerator (2 – 8°C). Do not freeze.
Single pen